0001889938-24-000002.txt : 20240912 0001889938-24-000002.hdr.sgml : 20240912 20240912164536 ACCESSION NUMBER: 0001889938-24-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240912 DATE AS OF CHANGE: 20240912 EFFECTIVENESS DATE: 20240912 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Anuncia Medical, Inc. CENTRAL INDEX KEY: 0001889938 ORGANIZATION NAME: IRS NUMBER: 824114865 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-523914 FILM NUMBER: 241295493 BUSINESS ADDRESS: STREET 1: 1355 N. SCOTTSDALE RD STREET 2: SUITE 370 CITY: SCOTTSDALE STATE: AZ ZIP: 85257 BUSINESS PHONE: (513)-500-6736 MAIL ADDRESS: STREET 1: 1355 N. SCOTTSDALE RD STREET 2: SUITE 370 CITY: SCOTTSDALE STATE: AZ ZIP: 85257 FORMER COMPANY: FORMER CONFORMED NAME: Anuncia, Inc. DATE OF NAME CHANGE: 20211022 D 1 primary_doc.xml X0708 D LIVE 0001889938 Anuncia Medical, Inc. 6908 E. Thomas Rd. SUITE 302 SCOTTSDALE AZ ARIZONA 85251 9789425600 DELAWARE Anuncia, Inc. Corporation true Elsa Abruzzo 6908 E. Thomas Rd. SUITE 302 SCOTTSDALE AZ ARIZONA 85251 Executive Officer Director PJ Anand 6908 E. Thomas Rd. SUITE 302 SCOTTSDALE AZ ARIZONA 85251 Director Richard Upton 6908 E. Thomas Rd. SUITE 302 SCOTTSDALE AZ ARIZONA 85251 Director David Donabedian 6908 E. Thomas Rd. SUITE 302 SCOTTSDALE AZ ARIZONA 85251 Director Edgar D Janotta 6908 E. Thomas Rd. SUITE 302 SCOTTSDALE AZ ARIZONA 85251 Director Stephen Oesterle 6908 E. Thomas Rd. SUITE 302 SCOTTSDALE AZ ARIZONA 85251 Director Stanton Rowe 6908 E. Thomas Rd. SUITE 302 SCOTTSDALE AZ ARIZONA 85251 Director Ghassan Kassab 6908 E. Thomas Rd. SUITE 302 SCOTTSDALE AZ ARIZONA 85251 Director Natalie Stevens 6908 E. Thomas Rd. SUITE 302 SCOTTSDALE AZ ARIZONA 85251 Executive Officer Biotechnology Decline to Disclose 06b false 2024-08-30 false true true true false 0 U.S. Boston Capital Corporation 5251 None None 55 Old Bedford Road Suite 202 Lincoln MA MASSACHUSETTS 01773 All States false 13422486 10751861 2670625 Amounts include conversion of outstanding promissory notes. In addition, the Company has offered 5-year warrants to purchase up to a maximum of 886,839 shares at $0.2819 per share. false 66 0 0 No sales to date have been subject to a commission or finders' fees expenses. 450000 true false Anuncia Medical, Inc. /s/ Elsa Abruzzo Elsa Abruzzo President and CEO 2024-09-12